CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.
about
Anacetrapib as a potential cardioprotective strategy.Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.Trials and Tribulations of CETP Inhibitors.Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
P2860
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
CETP (Cholesteryl Ester Transf ...... Hypercholesterolemic Subjects.
@en
type
label
CETP (Cholesteryl Ester Transf ...... Hypercholesterolemic Subjects.
@en
prefLabel
CETP (Cholesteryl Ester Transf ...... Hypercholesterolemic Subjects.
@en
P2093
P2860
P921
P1476
CETP (Cholesteryl Ester Transf ...... Hypercholesterolemic Subjects.
@en
P2093
Amy O Johnson-Levonas
Brian Hubbard
Daniel J Rader
David E Gutstein
Gissette Reyes-Soffer
Haihong Zhou
Henry N Ginsberg
John A Wagner
John S Millar
Patricia Jumes
P2860
P304
P356
10.1161/ATVBAHA.117.309549
P407
P577
2017-07-20T00:00:00Z